Posterior cervical laminoplasty in the North American Population: A minimum of two year follow-up

Clinical Neurology and Neurosurgery
Nitin N BhatiaFrank Eismont

Abstract

The efficacy of expansile cervical laminoplasty for cervical spondylotic myelopathy has been validated in the literature. To date, however, the majority of large, long-term data in the literature have originated in Japan. Few studies have originated from North America that include follow up greater than one year, and none of these includes a single surgeon's experience. This paper presents the retrospective results of a single surgeon with an average follow up of 47 months in a large population of North American patients. A single surgeon's series of 80 consecutive patients who underwent expansile open-door laminoplasty for cervical myelopathy was reviewed. The severity of disability was graded using the Nurick Functional Disability Score and the Miami Upper Extremity Function (MUEF) score. Patients were evaluated preoperatively, six months postoperatively, and at a minimum of 24 months postoperatively. All examinations were performed by a single physician. MRI scans of the cervical spine were obtained at four months postoperatively in all patients. Radiographs were used to evaluate postoperative lordosis. Average length of follow up was 47 months. Nurick scores improved from an average of 2.3 preoperatively to postoperative sc...Continue Reading

References

May 1, 1995·Journal of Neurosurgery·M J EbersoldL M Quast
Jul 15, 1997·Spine·M S Moon
Nov 12, 1998·Journal of Spinal Disorders·A R VaccaroS R Garfin
Jan 8, 1999·Spine·T J Albert, A Vacarro
Oct 23, 2002·The Orthopedic Clinics of North America·Matthew J Geck, Frank J Eismont
Sep 16, 2003·Spine·Kunihiko SasaiHirokazu Iida
Nov 1, 2003·The Spine Journal : Official Journal of the North American Spine Society·Chetan K PatelHarry N Herkowitz
Dec 20, 2003·Neurosurgery·Michael Y Wang, Barth A Green
Nov 16, 2004·The Spine Journal : Official Journal of the North American Spine Society·Masashi KomagataAtsuhiro Imakiire

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.